TRAZZI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 2.515
EU - Europa 1.933
AS - Asia 912
AF - Africa 177
SA - Sud America 10
OC - Oceania 4
Totale 5.551
Nazione #
US - Stati Uniti d'America 2.504
IT - Italia 810
GB - Regno Unito 365
CN - Cina 295
SG - Singapore 249
DE - Germania 223
VN - Vietnam 199
SE - Svezia 162
TG - Togo 90
IN - India 84
IE - Irlanda 73
FR - Francia 45
RU - Federazione Russa 44
BG - Bulgaria 39
CI - Costa d'Avorio 38
JO - Giordania 32
CH - Svizzera 28
ZA - Sudafrica 25
ES - Italia 22
EE - Estonia 21
NG - Nigeria 21
UA - Ucraina 19
FI - Finlandia 18
BE - Belgio 17
NL - Olanda 16
ID - Indonesia 12
CA - Canada 11
AT - Austria 8
HK - Hong Kong 8
JP - Giappone 8
HR - Croazia 6
TR - Turchia 6
IR - Iran 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
RO - Romania 4
AR - Argentina 3
BR - Brasile 3
DK - Danimarca 3
GR - Grecia 3
PE - Perù 3
PL - Polonia 3
LB - Libano 2
MA - Marocco 2
NO - Norvegia 2
PK - Pakistan 2
CL - Cile 1
KR - Corea 1
LK - Sri Lanka 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SM - San Marino 1
TH - Thailandia 1
Totale 5.551
Città #
Chandler 337
Bologna 315
Fairfield 290
Southend 255
Singapore 230
Ashburn 184
Houston 146
Santa Clara 133
Woodbridge 131
Wilmington 129
Dong Ket 128
Seattle 126
Ann Arbor 110
Lomé 90
Cambridge 87
Dublin 73
Princeton 72
Boardman 66
Bristol 54
Turin 50
Sofia 39
Abidjan 38
Falls Church 34
Redmond 34
Amman 32
Trento 31
Frankfurt am Main 30
Islington 29
Beijing 28
Westminster 28
Marano 27
Nanjing 27
New York 27
Berlin 26
Bern 25
Padova 24
Milan 22
Argelato 21
San Diego 21
Abeokuta 20
Bremen 18
Helsinki 17
Brussels 16
Rome 16
Hebei 15
Jerez De La Frontera 15
Saint Petersburg 14
Redwood City 13
Bolzano 12
Changsha 11
Jakarta 11
Nanchang 11
Des Moines 10
Forlì 10
Amsterdam 9
Guangzhou 8
Jinan 8
Modena 8
Paris 8
Shanghai 8
Taizhou 8
Bari 7
Dearborn 7
Florence 7
Medford 7
Pune 7
Shenyang 7
Tianjin 7
Boydton 6
Lanzhou 6
San Francisco 6
Toronto 6
Vienna 6
Wuhan 6
Cesena 5
Hyderabad 5
Jiaxing 5
Munich 5
Mülheim 5
Olalla 5
Ravenna 5
Bondeno 4
Chicago 4
Chongqing 4
Edmonton 4
Faenza 4
Ferrara 4
Fort Collins 4
Gagliano del Capo 4
Genoa 4
Hangzhou 4
London 4
Los Angeles 4
Monmouth Junction 4
Moscow 4
Mumbai 4
Norwalk 4
Piacenza 4
Rocca San Casciano 4
San Mateo 4
Totale 4.011
Nome #
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 241
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 213
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 192
Functional impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are ameliorated by a GABAB receptor antagonist 176
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 174
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 171
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 170
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 165
The C-Terminal Domain of CENP-C Displays Multiple and Critical Functions for Mammalian Centromere Formation. 160
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 158
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 157
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 156
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 156
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 154
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 151
Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice 145
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 144
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 143
Functional cooperation between TrkA and p75NTR accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities 134
null 130
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 129
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 129
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 128
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 122
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 121
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 121
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 121
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 120
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 120
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 119
DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions 118
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 117
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 116
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 107
CENP-C binds the alpha-satellite DNA in vivo at specific centromere domains 105
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 104
null 101
Artificial protein and its applications 80
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder 72
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 63
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 54
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 36
In vivo functional dissection of human inner kinetochore protein CENP-C 33
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 31
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome 17
Totale 5.674
Categoria #
all - tutte 14.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020581 0 0 0 0 0 0 118 137 159 58 53 56
2020/2021686 90 27 24 24 25 73 14 32 58 48 24 247
2021/2022926 62 45 73 70 86 56 42 57 44 78 166 147
2022/20231.420 111 227 74 168 120 122 38 81 228 33 110 108
2023/2024552 27 40 23 55 28 100 71 62 44 23 28 51
2024/2025859 104 165 141 144 208 93 4 0 0 0 0 0
Totale 5.674